[go: up one dir, main page]

MXPA03001653A - Delayed release compositions and combinations. - Google Patents

Delayed release compositions and combinations.

Info

Publication number
MXPA03001653A
MXPA03001653A MXPA03001653A MXPA03001653A MXPA03001653A MX PA03001653 A MXPA03001653 A MX PA03001653A MX PA03001653 A MXPA03001653 A MX PA03001653A MX PA03001653 A MXPA03001653 A MX PA03001653A MX PA03001653 A MXPA03001653 A MX PA03001653A
Authority
MX
Mexico
Prior art keywords
physiologically active
active protein
delayed release
combinations
release compositions
Prior art date
Application number
MXPA03001653A
Other languages
Spanish (es)
Inventor
William T H Chang
Original Assignee
Lytone Enterprise Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lytone Enterprise Inc filed Critical Lytone Enterprise Inc
Publication of MXPA03001653A publication Critical patent/MXPA03001653A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a delayed release composition of a physiologically active protein, which comprises an effective amount of the physiologically active protein, and fibrin glue in an amount effective to delay the release of the physiologically active protein. The present invention further relates to a delayed release combination of a physiologically active protein, which comprises an effective amount of the physiologically active protein, and fibrinogen and thrombin in an amount effective to delay the release of the physiologically active protein.
MXPA03001653A 2000-08-24 2000-08-24 Delayed release compositions and combinations. MXPA03001653A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/020799 WO2002015882A1 (en) 2000-08-24 2000-08-24 Delayed release compositions and combinations

Publications (1)

Publication Number Publication Date
MXPA03001653A true MXPA03001653A (en) 2004-09-10

Family

ID=21741635

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001653A MXPA03001653A (en) 2000-08-24 2000-08-24 Delayed release compositions and combinations.

Country Status (5)

Country Link
CN (1) CN1434703A (en)
AU (1) AU2000270527A1 (en)
BR (1) BR0017324A (en)
MX (1) MXPA03001653A (en)
WO (1) WO2002015882A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102872450B (en) * 2012-10-17 2014-09-03 中国人民解放军总医院 Composition for composite drug administration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9304075A (en) * 1992-07-08 1994-04-29 Applied Research Systems PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF CONSUMPTIVE THROMBOHEMORRHAGIC DISORDERS.
US5338836A (en) * 1992-07-29 1994-08-16 American Cyanamid Company Biologically active porcine somatotropin polypeptides and methods of using the same
CN1056973C (en) * 1993-10-04 2000-10-04 毛里齐奥·托内蒂 Pharmaceutical composition for promoting tissue healing and regeneration and administration kit containing same
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies

Also Published As

Publication number Publication date
WO2002015882A8 (en) 2002-03-28
AU2000270527A1 (en) 2002-03-04
CN1434703A (en) 2003-08-06
BR0017324A (en) 2003-07-29
WO2002015882A1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
EE200300348A (en) Solid composition consisting predominantly of collagen carrier, solid fibrinogen and solid thrombin and its use
WO1998057678A3 (en) Compositions containing thrombin and microfibrillar collagen
PL365817A1 (en) Stable solid enzyme compositions and methods employing them
EP1023017A4 (en) Fibrin glue without fibrinogen and biosealant compositions and methods
MY129150A (en) Novel sulfamides
WO2003059296A3 (en) Compositions comprising collagen and metalloprotease inhibitors
GB0112586D0 (en) Decellularisation of matrices
MXPA02012206A (en) Compositions containing therapeutically active components having enhanced solubility.
DK1157037T3 (en) G-CSF-conjugates
DE60120712D1 (en) Kallikrein gen
EP1545608A4 (en) Mammalian ch1 deleted mimetibodies, compositions, methods and uses
AU2002210529A1 (en) Shear gel compositions
WO2002005800A3 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
WO2000076933A3 (en) Water-resistant gypsum composition
IL179852A0 (en) Thrombin compositions
ATE252375T1 (en) BIODEGRADABLE MICROPARTICLES WITH DELAYED RELEASE
WO1999064001A3 (en) Methods and compositions for increasing penetration of hiv protease inhibitors
WO2001096366A3 (en) Dipeptide inhibitors for the blood-clotting factor xa
MXPA03001653A (en) Delayed release compositions and combinations.
MXPA03000430A (en) Novel arylethene-sulfonamides.
WO2002002519A3 (en) THROMBIN OR FACTOR Xa INHIBITORS
MXPA03011128A (en) Flavour and fragrance compositions.
WO2004110469A3 (en) Formulations comprising factor viia and a factor vii related polypeptide
WO2004053040A3 (en) Encapsulated, defoaming bleaches and cleaning compositions containing them
YU25903A (en) Pesticidal composition